Abstract
The morphological, functional, and genetic abnormalities are heterogeneous in different patient populations with hypertrophie cardiomyopathy (HCM) [1–8]; as a consequence, the natural history and the clinical course are extremely variable and prognostic evaluation is a challenging task in the individual patient.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Frank S, Braunwald E (1968) Idiopathic hypertrophic subaortic stenosis: clinical analysis of 126 patients with emphasis on the natural history. Circulation 37:759–787
Goodwin JF. (1970) Congestive and hypertrophic cardiomyopathies: a decade of study. Lancet 1:732–739
Wigle ED, Sasson Z, Henderson MA, et al. (1985) Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy: a review. Prog Cardiovasc Dis 28:1–83
Maron BJ, Spirito P, Wesley Y, Arce J (1986) Development and progression of left ventricular hypertrophy in children with hypertrophie cardiomyopathy. N Engl J Med 315:610–614
Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE (1987) Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316:780–844
Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C, (1989) Clinical course and prognosis of hypertrophie cardiomyopathy in an outpatient population. N Engl J Med 320:749–761
Louie EK, Edwards LC III (1994) Hypertrophic cardiomyopathy. Prog Cardiovasc Dis 36:275–308
Wigle ED, Rakowski Hypertrophy, Kimball BP, Williams WG (1995) Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 92:1680–1682
Shah PM, Adelman AG, Wigle ED, et al (1973) The natural (and unnatural) history of hypertrophie obstructive cardiomyopathy. Circ Res 34,35 [Supp1 II]: II179–185
Maron BJ, Roberts WC, Epstein SE (1982) Sudden death in hypertrophie cardiomyopathy: profile of 78 patients. Circulation 65:1388–1394
Swan DA, Bell B, Oakley C, Goodwin J (1971) Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Br Heart J 33:671–675
Hardarson T, De La Calzada CS, Curiel JF (1973) Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet 2:1462–1464
Loogen F, Kuhn H, Gietzen F, Losse B, Schulte HD, Bircks W (1983) Clinical course and prognosis of patients with atypical hypertrophic obstructive and hypertrophie nonobstructive cardiomyopathy. Eur Heart J 4 [Suppl. F]:145–151
Hect GM, Panza JA, Maron BJ (1992) Clinical course of middle-aged asymptomatic patients with hypertrophie cardiomyopathy. Am J Cardiol 69:935–940
McKenna WJ, Deanfield JE (1984) Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child 59:971–976
Maron BJ, Lipson LC, Roberts WC, Savage DD, Epstein SE. (1978) “Malignant ” hypertrophie cardiomyopathy: identification of a subgroup of families with unusually frequent premature deaths. Am J Cardiol 41:1133–1140
Fiddler GI, Tajik AJ, Weidman WH, McGoon DC, Ritter DG, Giuliani ER (1978) Idiopathic hypertrophie subaortic stenosis in the young. Am J Cardiol 42:793–799
Cecchi F, Maron BJ, Epstein SE (1989) Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after arrest. J Am Coll Cardiol 13:1283–1288
McKenna WJ, Camm AJ (1989) Sudden death in hypertrophie cardiomyopathy: assessment of patients at high risk. Circulation 80:1489–1494
Maron BJ, Henry WL, Clark CE, Redwood DR, Roberts WC, Epstein SE (1976) Asymmetric septal hypertrophy in childhood. Circulation 53:9–14
Shapiro LM, Zezulka A (1983) Hypertrophic cardiomyopathy: a common disease with a good prognosis: five year experience of a district general hospital. Br Heart J 50:530–533
Kofflard MJ, Waldstein DJ, Vos J, ten Cate FJ (1993) Prognosis in hypertrophie cardiomyopathy observed in a large clinic population. Am J Cardiol 72:939–943
Maron BJ, Spirito P (1993) Impact of patient selection biases on the perception of hypertrophie cardiomyopathy and its natural history. Am J Cardiol 72:970–972
Spirito P, Rapezzi C, Autore C, et al. (1994) Prognosis of asymptomatic patients with hypertrophie cardiomyopathy and nonsustained ventricular tachicardia. Circulation 90:2743–2747
Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ (1995) Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 26:1529–1534
Cannan CR, Reeder GS, Bailey KR, Melton LJ III, Gersh BJ (1995) Natural history of hypertrophie cardiomyopathy: a population based study, 1976 through 1990. Circulation 92:2488–2495
Spirito P, Seidman CE, McKenna WJ, Maron BJ (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 11:775–785
Author information
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Italia
About this paper
Cite this paper
Lazzeroni, E. et al. (1998). The Italian Multicentric Study on Hypertrophic Cardiomyopathy: II. Prognostic Assessment in Symptomatic Patients. In: Camerini, F., Gavazzi, A., De Maria, R. (eds) Advances in Cardiomyopathies. Springer, Milano. https://doi.org/10.1007/978-88-470-2155-6_5
Download citation
DOI: https://doi.org/10.1007/978-88-470-2155-6_5
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2181-5
Online ISBN: 978-88-470-2155-6
eBook Packages: Springer Book Archive